Skip to search boxSkip to navigationSkip to main content

Internal ribosome entry site (IRES) from Encephalomyocarditis virus (EMCV) as a tool for shuttle expression plasmids

  • Sandra Aurora Telpalo-Carpiob(Author)
    ,
  • Francisco Diaz-Mitomab(Author)
    ,
  • ,
  • José Manuel Aguilar-Yáñeza, b(Author)
  • aInstituto Tecnologico de Estudios Superiores de Monterrey
    ,
  • bAdvanced Medical Research Institute of Canada
    ,
  • cCenter for Health Innovation and Transfer (CITES)
Research Output: Contribution to journal Article Peer-review

Publication metrics

Metrics

SciVal
FWCI
0.09
SciVal
Author count
4
SciVal
Citations
3
SciVal
Paper percentile
32
Scopus
Citations

PlumX, opens in new tab

Citations
2
Captures
34

Abstract

In eukaryotes, IRES sequences aid the recruitment of factors needed for translation to occur, enabling protein production independent of 5′ capped mRNA. Many patents and commercially available plasmids exploit their properties for polycistronic expression of recombinant proteins. However, these applications have been restricted to eukaryotic organisms, since it was thought that elements of this origin were essential for their activity. Here, using two tricistronic vectors designed for expression in mammalian hosts, we present evidence of EMCV IRES activity in prokaryotes. This finding enables the development of new and more versatile plasmid vectors for the production of recombinant proteins in multiple hosts from a single construct. Additionally, it provides new hints for the elaboration of alternative models describing the molecular mechanism of EMCV IRES mediated translation, in the absence of eukaryotic elements that were considered indispensable for its function.

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 548-553 (6 pages)

Journal (Volume, Issue Number)

Biochemical and Biophysical Research Communications (Volume 468, Issue 4)

Publication milestones

  • Published - 25/12/2015

Publication status

Published - 25/12/2015

ISSN

0006-291X

External Publication IDs

  • Scopus: 84949579954
  • PubMed: 26546818

Funding Details

Thanks to Consejo Nacional de Ciencia y Tecnología (CONACyT) for the support given to the 296956 CVU holder. Dr. Justo Pérez, Dr. Reza Nokhbeh and M.Sc. Nya Fraleigh for all the facilities given for the experiments completion. Members of the Vaccine Group at AMRIC and members of the Cell Therapy and Regenerative Medicine Endowment at ITESM for the help given during the development of this project. M.Sc. BongMin Bae and M.Sc. César Ortiz for the proof reading of the manuscript. M.Sc. Juan Antonio Rubio-Lara for the support during the writing of the manuscript. Appendix A